Clinical Research Directory

Inclusion Criteria: * Adult male or female aged 18-75 years * Not respond to initial empirical treatment, treatment time to reach Eravacycline steady-state concentration * Empirical antimicrobial treatment is ineffective * Eravacycline application for ≥ 3 days * Understand and sign informed consent Exclusion Criteria: * Urinary tract infection * Allergic to Eravacycline, Tigecycline antibiotics or any excipients or have previously experienced serious adverse reactions * Any unstable or potentially endangering the safety of the subject and their compliance with the study as judged by the investigator; comorbidities or social circumstances that can make the subject unable to follow the study plan or even endanger the safety of the patient * Patients expected to survive for no longer than 48h.